• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated.

作者信息

Lazarinis Nikolaos, Bossios Apostolos, Gülen Theo

机构信息

Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Clinical Immunology and Allergy Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Mastocytosis Center Karolinska, Karolinska Institutet and Karolinska University, Hospital Huddinge, Stockholm, Sweden.

出版信息

J Allergy Clin Immunol Pract. 2022 May;10(5):1377-1379. doi: 10.1016/j.jaip.2022.01.037. Epub 2022 Feb 3.

DOI:10.1016/j.jaip.2022.01.037
PMID:35123098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8810433/
Abstract
摘要

相似文献

1
COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated.在肥大细胞增多症患者中接种新冠病毒疫苗——辉瑞-BioNTech信使核糖核酸疫苗是安全的，且耐受性良好。
J Allergy Clin Immunol Pract. 2022 May;10(5):1377-1379. doi: 10.1016/j.jaip.2022.01.037. Epub 2022 Feb 3.
2
Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?深入研究新冠疫苗接种引起的过敏反应：mRNA疫苗在肥大细胞疾病中是否安全？
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):193-195. doi: 10.18176/jiaci.0680. Epub 2021 Feb 12.
3
COVID-19 Vaccines Are Safely Tolerated in Adolescents with Cutaneous Mastocytosis.COVID-19 疫苗在患有皮肤肥大细胞增多症的青少年中安全耐受。
Int Arch Allergy Immunol. 2023;184(8):776-782. doi: 10.1159/000530125. Epub 2023 Apr 18.
4
Latent Mastocytosis Triggered by COVID-19 Vaccination: A Case Report.COVID-19 疫苗接种引发的潜伏性肥大细胞增多症：一例报告。
Endocr Metab Immune Disord Drug Targets. 2024;24(4):495-498. doi: 10.2174/0118715303241179230927105454.
5
Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US.美国同时接种 COVID-19 mRNA 加强针和流感疫苗的反应原性。
JAMA Netw Open. 2022 Jul 1;5(7):e2222241. doi: 10.1001/jamanetworkopen.2022.22241.
6
Vaccine Side Effects Following COVID-19 Vaccination Among the Residents of the UAE-An Observational Study.阿联酋居民接种 COVID-19 疫苗后的副作用：一项观察性研究。
Front Public Health. 2022 May 6;10:876336. doi: 10.3389/fpubh.2022.876336. eCollection 2022.
7
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.在报告 Janssen（强生）和 mRNA COVID-19 疫苗（辉瑞-生物科技和莫德纳）成年受种者发生不良事件后使用 COVID-19 疫苗：免疫实践咨询委员会的更新-美国，2021 年 7 月。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1094-1099. doi: 10.15585/mmwr.mm7032e4.
8
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination.mRNA COVID-19 疫苗接种后迟发性全身性荨麻疹反应。
Allergy Asthma Proc. 2022 Jan 1;43(1):40-43. doi: 10.2500/aap.2022.43.210101.
9
Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.疫苗安全数据链接中 COVID-19 疫苗接种后吉兰-巴雷综合征的发生率。
JAMA Netw Open. 2022 Apr 1;5(4):e228879. doi: 10.1001/jamanetworkopen.2022.8879.
10
Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis.一名银屑病患者接种第一剂辉瑞-生物科技公司BNT16B2b2 COVID-19 mRNA疫苗后出现红皮病。
Dermatol Ther. 2022 May;35(5):e15363. doi: 10.1111/dth.15363. Epub 2022 Feb 14.

引用本文的文献

1
COVID-19 mRNA-1273 vaccination induced mast cell activation with strongly elevated Th cytokines in a systemic mastocytosis patient.在一名系统性肥大细胞增多症患者中，COVID-19 mRNA-1273疫苗接种诱导肥大细胞活化，并伴有Th细胞因子显著升高。
Inflamm Res. 2025 Apr 29;74(1):71. doi: 10.1007/s00011-025-02032-5.
2
Vaccine hesitancy in patients presenting to a specialized allergy center: clinical relevant sensitizations, impact on mental health and vaccination rates.专门过敏中心就诊患者的疫苗犹豫：临床相关致敏情况、对心理健康的影响和疫苗接种率。
Front Immunol. 2024 May 17;15:1324987. doi: 10.3389/fimmu.2024.1324987. eCollection 2024.
3
Challenges in Drug and Hymenoptera Venom Hypersensitivity Diagnosis and Management in Mastocytosis.肥大细胞增多症中药物和膜翅目毒液超敏反应诊断与管理的挑战
Diagnostics (Basel). 2024 Jan 5;14(2):123. doi: 10.3390/diagnostics14020123.
4
COVID-19 vaccination acceptance, safety and side-effects in European patients with severe asthma.欧洲重症哮喘患者对新冠疫苗的接受度、安全性及副作用
ERJ Open Res. 2023 Nov 27;9(6). doi: 10.1183/23120541.00590-2023. eCollection 2023 Nov.
5
Latent Mastocytosis Triggered by COVID-19 Vaccination: A Case Report.COVID-19 疫苗接种引发的潜伏性肥大细胞增多症：一例报告。
Endocr Metab Immune Disord Drug Targets. 2024;24(4):495-498. doi: 10.2174/0118715303241179230927105454.
6
SARS-CoV-2 and allergy - what have we learned after two and a half years?新型冠状病毒2型与过敏——两年半后我们了解到了什么？
Allergol Select. 2023 Mar 31;7:101-112. doi: 10.5414/ALX02373E. eCollection 2023.
7
Non-steroidal anti-inflammatory drug-induced anaphylaxis infrequent in 388 patients with mastocytosis: A two-center retrospective cohort study.388例肥大细胞增多症患者中，非甾体类抗炎药诱发过敏反应不常见：一项双中心回顾性队列研究。
Front Allergy. 2022 Dec 5;3:1071807. doi: 10.3389/falgy.2022.1071807. eCollection 2022.
8
The conundrum of COVID-19 mRNA vaccine-induced anaphylaxis.新型冠状病毒肺炎信使核糖核酸疫苗诱导的过敏反应难题。
J Allergy Clin Immunol Glob. 2023 Feb;2(1):1-13. doi: 10.1016/j.jacig.2022.10.003. Epub 2022 Dec 13.
9
Treatment of Advanced Systemic Mastocytosis with Midostaurin: Practical Guidance for Optimal Therapy and Management.米哚妥林治疗晚期系统性肥大细胞增多症：最佳治疗与管理的实用指南
Mediterr J Hematol Infect Dis. 2022 Nov 1;14(1):e2022073. doi: 10.4084/MJHID.2022.073. eCollection 2022.
10
Incidence of symptomatic Covid-19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population.肥大细胞增多症和慢性髓性白血病患者中症状性新冠病毒感染的发生率：与奥地利普通人群的比较。
Eur J Haematol. 2023 Jan;110(1):67-76. doi: 10.1111/ejh.13875. Epub 2022 Oct 17.

本文引用的文献

1
Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.高过敏风险成年人接种辉瑞-BioNTech COVID-19 疫苗后的过敏反应发生率。
JAMA Netw Open. 2021 Aug 2;4(8):e2122255. doi: 10.1001/jamanetworkopen.2021.22255.
2
Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders.BNT162b2 mRNA新冠疫苗在肥大细胞疾病患者中的安全性
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3487-3489. doi: 10.1016/j.jaip.2021.06.032. Epub 2021 Jul 2.
3
Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome.肥大细胞增多症和单克隆肥大细胞活化综合征患者接种新型冠状病毒疫苗的安全性
J Allergy Clin Immunol Pract. 2021 Aug;9(8):3198-3199. doi: 10.1016/j.jaip.2021.05.010. Epub 2021 May 24.
4
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM).肥大细胞增多症患者的COVID-19疫苗接种：欧洲肥大细胞增多症专家网络（ECNM）和美国肥大细胞疾病倡议组织（AIM）的建议
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2139-2144. doi: 10.1016/j.jaip.2021.03.041. Epub 2021 Apr 5.
5
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.美国 2020 年 12 月 14 日至 23 日：在接种第一剂辉瑞-BioNTech COVID-19 疫苗后出现过敏反应（包括过敏反应）。
MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46-51. doi: 10.15585/mmwr.mm7002e1.
6
Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protection.克隆性肥大细胞疾病患者的毒液免疫疗法：IgG4与保护作用相关。
Allergy. 2020 Jan;75(1):169-177. doi: 10.1111/all.13980. Epub 2019 Aug 12.
7
Vaccination management in children and adults with mastocytosis.肥大细胞增多症儿童和成人的疫苗接种管理
Clin Exp Allergy. 2017 Apr;47(4):593-596. doi: 10.1111/cea.12882. Epub 2017 Feb 27.
8
Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.肥大细胞增多症：一种神秘疾病的令人费解的临床谱和具有挑战性的诊断方面。
J Intern Med. 2016 Mar;279(3):211-28. doi: 10.1111/joim.12410. Epub 2015 Sep 8.
9
High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.系统性肥大细胞增多症患者中过敏反应的高患病率——单中心经验
Clin Exp Allergy. 2014 Jan;44(1):121-9. doi: 10.1111/cea.12225.